CD169	B:C0142251
is	O
a	O
marker	O
for	O
highly	O
pathogenic	O
phagocytes	O
in	O
multiple	O
sclerosis	I:C0026769
.	O

CD169	O
is	O
a	O
marker	B:C0005516
for	O
highly	O
pathogenic	O
phagocytes	O
in	O
multiple	O
sclerosis	I:C0026769
.	O

CD169	O
is	O
a	O
marker	O
for	O
highly	O
pathogenic	O
phagocytes	B:C0031307
in	O
multiple	O
sclerosis	I:C0026769
.	O

CD169	O
is	O
a	O
marker	O
for	O
highly	O
pathogenic	O
phagocytes	O
in	O
multiple	B:C0026769
sclerosis	I:C0026769
.	O

Phagocytes	B:C0031307
,	O
such	O
as	O
macrophages	O
and	O
microglia	O
,	O
are	O
key	O
effector	O
cells	I:C0312740
in	O
the	O
pathophysiology	O
of	O
multiple	O
sclerosis	I:C0026769
(	O
multiple	O
sclerosis	I:C0026769
)	O
.	O

Phagocytes	O
,	O
such	O
as	O
macrophages	B:C0024432
and	O
microglia	O
,	O
are	O
key	O
effector	O
cells	I:C0312740
in	O
the	O
pathophysiology	O
of	O
multiple	O
sclerosis	I:C0026769
(	O
multiple	O
sclerosis	I:C0026769
)	O
.	O

Phagocytes	O
,	O
such	O
as	O
macrophages	O
and	O
microglia	B:C0206116
,	O
are	O
key	O
effector	O
cells	I:C0312740
in	O
the	O
pathophysiology	O
of	O
multiple	O
sclerosis	I:C0026769
(	O
multiple	O
sclerosis	I:C0026769
)	O
.	O

Phagocytes	O
,	O
such	O
as	O
macrophages	O
and	O
microglia	O
,	O
are	O
key	O
effector	B:C0312740
cells	I:C0312740
in	O
the	O
pathophysiology	O
of	O
multiple	O
sclerosis	I:C0026769
(	O
multiple	O
sclerosis	I:C0026769
)	O
.	O

Phagocytes	O
,	O
such	O
as	O
macrophages	O
and	O
microglia	O
,	O
are	O
key	O
effector	O
cells	I:C0312740
in	O
the	O
pathophysiology	O
of	O
multiple	B:C0026769
sclerosis	I:C0026769
(	O
multiple	O
sclerosis	I:C0026769
)	O
.	O

Phagocytes	O
,	O
such	O
as	O
macrophages	O
and	O
microglia	O
,	O
are	O
key	O
effector	O
cells	I:C0312740
in	O
the	O
pathophysiology	O
of	O
multiple	O
sclerosis	I:C0026769
(	O
multiple	B:C0026769
sclerosis	I:C0026769
)	O
.	O

It	O
is	O
widely	O
accepted	O
that	O
they	O
instigate	O
and	O
promote	O
neuroinflammatory	O
and	O
neurodegenerative	B:C0027746
events	O
in	O
multiple	O
sclerosis	I:C0026769
.	O

It	O
is	O
widely	O
accepted	O
that	O
they	O
instigate	O
and	O
promote	O
neuroinflammatory	O
and	O
neurodegenerative	O
events	O
in	O
multiple	B:C0026769
sclerosis	I:C0026769
.	O

An	O
increasing	O
amount	O
of	O
studies	B:C2603343
indicate	O
that	O
Siglec	O
-	I:C0142251
1	I:C0142251
,	O
also	O
known	O
CD169	O
,	O
is	O
a	O
marker	O
for	O
activated	O
phagocytes	O
in	O
inflammatory	O
disorders	I:C1290884
.	O

An	O
increasing	O
amount	O
of	O
studies	O
indicate	O
that	O
Siglec	B:C0142251
-	I:C0142251
1	I:C0142251
,	O
also	O
known	O
CD169	O
,	O
is	O
a	O
marker	O
for	O
activated	O
phagocytes	O
in	O
inflammatory	O
disorders	I:C1290884
.	O

An	O
increasing	O
amount	O
of	O
studies	O
indicate	O
that	O
Siglec	O
-	I:C0142251
1	I:C0142251
,	O
also	O
known	O
CD169	B:C0142251
,	O
is	O
a	O
marker	O
for	O
activated	O
phagocytes	O
in	O
inflammatory	O
disorders	I:C1290884
.	O

An	O
increasing	O
amount	O
of	O
studies	O
indicate	O
that	O
Siglec	O
-	I:C0142251
1	I:C0142251
,	O
also	O
known	O
CD169	O
,	O
is	O
a	O
marker	B:C0005516
for	O
activated	O
phagocytes	O
in	O
inflammatory	O
disorders	I:C1290884
.	O

An	O
increasing	O
amount	O
of	O
studies	O
indicate	O
that	O
Siglec	O
-	I:C0142251
1	I:C0142251
,	O
also	O
known	O
CD169	O
,	O
is	O
a	O
marker	O
for	O
activated	O
phagocytes	B:C0031307
in	O
inflammatory	O
disorders	I:C1290884
.	O

An	O
increasing	O
amount	O
of	O
studies	O
indicate	O
that	O
Siglec	O
-	I:C0142251
1	I:C0142251
,	O
also	O
known	O
CD169	O
,	O
is	O
a	O
marker	O
for	O
activated	O
phagocytes	O
in	O
inflammatory	B:C1290884
disorders	I:C1290884
.	O

In	O
this	O
study	B:C2603343
,	O
we	O
set	O
out	O
to	O
define	O
how	O
CD169	O
(+	I:C0142251
)	I:C0142251
phagocytes	O
contribute	O
to	O
neuroinflammation	O
in	O
multiple	O
sclerosis	I:C0026769
.	O

In	O
this	O
study	O
,	O
we	O
set	O
out	O
to	O
define	O
how	O
CD169	B:C0142251
(+	I:C0142251
)	I:C0142251
phagocytes	O
contribute	O
to	O
neuroinflammation	O
in	O
multiple	O
sclerosis	I:C0026769
.	O

In	O
this	O
study	O
,	O
we	O
set	O
out	O
to	O
define	O
how	O
CD169	O
(+	I:C0142251
)	I:C0142251
phagocytes	B:C0031307
contribute	O
to	O
neuroinflammation	O
in	O
multiple	O
sclerosis	I:C0026769
.	O

In	O
this	O
study	O
,	O
we	O
set	O
out	O
to	O
define	O
how	O
CD169	O
(+	I:C0142251
)	I:C0142251
phagocytes	O
contribute	O
to	O
neuroinflammation	B:C0021368
in	O
multiple	O
sclerosis	I:C0026769
.	O

In	O
this	O
study	O
,	O
we	O
set	O
out	O
to	O
define	O
how	O
CD169	O
(+	I:C0142251
)	I:C0142251
phagocytes	O
contribute	O
to	O
neuroinflammation	O
in	O
multiple	B:C0026769
sclerosis	I:C0026769
.	O

CD169	B:C0142251
-	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
(	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
)	O
mice	O
,	O
which	O
express	O
human	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
under	O
control	O
of	O
the	O
CD169	O
promoter	O
,	O
were	O
used	O
to	O
define	O
the	O
impact	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
on	O
neuroinflammation	O
.	O

CD169	O
-	O
diphtheria	B:C0058402
toxin	I:C0058402
receptor	I:C0058402
(	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
)	O
mice	O
,	O
which	O
express	O
human	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
under	O
control	O
of	O
the	O
CD169	O
promoter	O
,	O
were	O
used	O
to	O
define	O
the	O
impact	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
on	O
neuroinflammation	O
.	O

CD169	O
-	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
(	O
diphtheria	B:C0058402
toxin	I:C0058402
receptor	I:C0058402
)	O
mice	O
,	O
which	O
express	O
human	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
under	O
control	O
of	O
the	O
CD169	O
promoter	O
,	O
were	O
used	O
to	O
define	O
the	O
impact	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
on	O
neuroinflammation	O
.	O

CD169	O
-	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
(	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
)	O
mice	B:C0025929
,	O
which	O
express	O
human	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
under	O
control	O
of	O
the	O
CD169	O
promoter	O
,	O
were	O
used	O
to	O
define	O
the	O
impact	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
on	O
neuroinflammation	O
.	O

CD169	O
-	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
(	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
)	O
mice	O
,	O
which	O
express	O
human	B:C0086418
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
under	O
control	O
of	O
the	O
CD169	O
promoter	O
,	O
were	O
used	O
to	O
define	O
the	O
impact	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
on	O
neuroinflammation	O
.	O

CD169	O
-	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
(	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
)	O
mice	O
,	O
which	O
express	O
human	O
diphtheria	B:C0058402
toxin	I:C0058402
receptor	I:C0058402
under	O
control	O
of	O
the	O
CD169	O
promoter	O
,	O
were	O
used	O
to	O
define	O
the	O
impact	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
on	O
neuroinflammation	O
.	O

CD169	O
-	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
(	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
)	O
mice	O
,	O
which	O
express	O
human	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
under	O
control	O
of	O
the	O
CD169	B:C1420266
promoter	O
,	O
were	O
used	O
to	O
define	O
the	O
impact	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
on	O
neuroinflammation	O
.	O

CD169	O
-	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
(	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
)	O
mice	O
,	O
which	O
express	O
human	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
under	O
control	O
of	O
the	O
CD169	O
promoter	B:C0086860
,	O
were	O
used	O
to	O
define	O
the	O
impact	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
on	O
neuroinflammation	O
.	O

CD169	O
-	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
(	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
)	O
mice	O
,	O
which	O
express	O
human	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
under	O
control	O
of	O
the	O
CD169	O
promoter	O
,	O
were	O
used	O
to	O
define	O
the	O
impact	O
of	O
CD169	B:C0142251
(+	I:C0142251
)	I:C0142251
cells	O
on	O
neuroinflammation	O
.	O

CD169	O
-	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
(	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
)	O
mice	O
,	O
which	O
express	O
human	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
under	O
control	O
of	O
the	O
CD169	O
promoter	O
,	O
were	O
used	O
to	O
define	O
the	O
impact	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	B:C0007634
on	O
neuroinflammation	O
.	O

CD169	O
-	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
(	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
)	O
mice	O
,	O
which	O
express	O
human	O
diphtheria	O
toxin	I:C0058402
receptor	I:C0058402
under	O
control	O
of	O
the	O
CD169	O
promoter	O
,	O
were	O
used	O
to	O
define	O
the	O
impact	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
on	O
neuroinflammation	B:C0021368
.	O

Flow	B:C0016263
cytometry	I:C0016263
and	O
immunohistochemistry	O
were	O
utilized	O
to	O
determine	O
the	O
expression	O
and	O
distribution	O
of	O
CD169	O
.	O

Flow	O
cytometry	I:C0016263
and	O
immunohistochemistry	B:C0021044
were	O
utilized	O
to	O
determine	O
the	O
expression	O
and	O
distribution	O
of	O
CD169	O
.	O

Flow	O
cytometry	I:C0016263
and	O
immunohistochemistry	O
were	O
utilized	O
to	O
determine	O
the	O
expression	O
and	O
distribution	O
of	O
CD169	B:C0142251
.	O

We	O
show	O
that	O
CD169	B:C0142251
is	O
highly	O
expressed	O
by	O
lesional	O
and	O
circulating	O
phagocytes	O
in	O
multiple	O
sclerosis	I:C0026769
and	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
.	O

We	O
show	O
that	O
CD169	O
is	O
highly	O
expressed	O
by	O
lesional	B:C0221198
and	O
circulating	O
phagocytes	O
in	O
multiple	O
sclerosis	I:C0026769
and	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
.	O

We	O
show	O
that	O
CD169	O
is	O
highly	O
expressed	O
by	O
lesional	O
and	O
circulating	B:C1516559
phagocytes	O
in	O
multiple	O
sclerosis	I:C0026769
and	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
.	O

We	O
show	O
that	O
CD169	O
is	O
highly	O
expressed	O
by	O
lesional	O
and	O
circulating	O
phagocytes	B:C0031307
in	O
multiple	O
sclerosis	I:C0026769
and	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
.	O

We	O
show	O
that	O
CD169	O
is	O
highly	O
expressed	O
by	O
lesional	O
and	O
circulating	O
phagocytes	O
in	O
multiple	B:C0026769
sclerosis	I:C0026769
and	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
.	O

We	O
show	O
that	O
CD169	O
is	O
highly	O
expressed	O
by	O
lesional	O
and	O
circulating	O
phagocytes	O
in	O
multiple	O
sclerosis	I:C0026769
and	O
experimental	B:C0014072
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
.	O

We	O
show	O
that	O
CD169	O
is	O
highly	O
expressed	O
by	O
lesional	O
and	O
circulating	O
phagocytes	O
in	O
multiple	O
sclerosis	I:C0026769
and	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
experimental	B:C0014072
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
.	O

Our	O
data	O
further	O
indicate	O
that	O
CD169	B:C0142251
represents	O
a	O
selective	O
marker	O
for	O
early	O
activated	O
microglia	I:C0206116
in	O
multiple	O
sclerosis	I:C0026769
and	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
lesions	O
.	O

Our	O
data	O
further	O
indicate	O
that	O
CD169	O
represents	O
a	O
selective	O
marker	B:C0005516
for	O
early	O
activated	O
microglia	I:C0206116
in	O
multiple	O
sclerosis	I:C0026769
and	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
lesions	O
.	O

Our	O
data	O
further	O
indicate	O
that	O
CD169	O
represents	O
a	O
selective	O
marker	O
for	O
early	O
activated	B:C0206116
microglia	I:C0206116
in	O
multiple	O
sclerosis	I:C0026769
and	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
lesions	O
.	O

Our	O
data	O
further	O
indicate	O
that	O
CD169	O
represents	O
a	O
selective	O
marker	O
for	O
early	O
activated	O
microglia	I:C0206116
in	O
multiple	B:C0026769
sclerosis	I:C0026769
and	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
lesions	O
.	O

Our	O
data	O
further	O
indicate	O
that	O
CD169	O
represents	O
a	O
selective	O
marker	O
for	O
early	O
activated	O
microglia	I:C0206116
in	O
multiple	O
sclerosis	I:C0026769
and	O
experimental	B:C0014072
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
lesions	O
.	O

Our	O
data	O
further	O
indicate	O
that	O
CD169	O
represents	O
a	O
selective	O
marker	O
for	O
early	O
activated	O
microglia	I:C0206116
in	O
multiple	O
sclerosis	I:C0026769
and	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
lesions	B:C0221198
.	O

Depletion	O
of	O
CD169	B:C0142251
(+	I:C0142251
)	I:C0142251
cells	O
markedly	O
reduced	O
neuroinflammation	O
and	O
ameliorated	O
disease	O
symptoms	O
in	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
-	O
affected	O
mice	O
.	O

Depletion	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	B:C0007634
markedly	O
reduced	O
neuroinflammation	O
and	O
ameliorated	O
disease	O
symptoms	O
in	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
-	O
affected	O
mice	O
.	O

Depletion	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
markedly	O
reduced	O
neuroinflammation	B:C0021368
and	O
ameliorated	O
disease	O
symptoms	O
in	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
-	O
affected	O
mice	O
.	O

Depletion	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
markedly	O
reduced	O
neuroinflammation	O
and	O
ameliorated	O
disease	B:C0012634
symptoms	O
in	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
-	O
affected	O
mice	O
.	O

Depletion	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
markedly	O
reduced	O
neuroinflammation	O
and	O
ameliorated	O
disease	O
symptoms	B:C1457887
in	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
-	O
affected	O
mice	O
.	O

Depletion	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
markedly	O
reduced	O
neuroinflammation	O
and	O
ameliorated	O
disease	O
symptoms	O
in	O
experimental	B:C0014072
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
-	O
affected	O
mice	O
.	O

Depletion	O
of	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
markedly	O
reduced	O
neuroinflammation	O
and	O
ameliorated	O
disease	O
symptoms	O
in	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
-	O
affected	O
mice	B:C0025929
.	O

Our	O
findings	B:C0243095
indicate	O
that	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
promote	O
neuroinflammation	O
.	O

Our	O
findings	O
indicate	O
that	O
CD169	B:C0142251
(+	I:C0142251
)	I:C0142251
cells	O
promote	O
neuroinflammation	O
.	O

Our	O
findings	O
indicate	O
that	O
CD169	O
(+	I:C0142251
)	I:C0142251
cells	O
promote	O
neuroinflammation	B:C0021368
.	O

Furthermore	O
,	O
they	O
suggest	O
that	O
CD169	B:C0142251
(+	I:C0142251
)	I:C0142251
phagocytes	O
play	O
a	O
key	O
role	O
in	O
the	O
pathophysiology	O
of	O
multiple	O
sclerosis	I:C0026769
.	O

Furthermore	O
,	O
they	O
suggest	O
that	O
CD169	O
(+	I:C0142251
)	I:C0142251
phagocytes	B:C0031307
play	O
a	O
key	O
role	O
in	O
the	O
pathophysiology	O
of	O
multiple	O
sclerosis	I:C0026769
.	O

Furthermore	O
,	O
they	O
suggest	O
that	O
CD169	O
(+	I:C0142251
)	I:C0142251
phagocytes	O
play	B:C0600138
a	O
key	O
role	O
in	O
the	O
pathophysiology	O
of	O
multiple	O
sclerosis	I:C0026769
.	O

Furthermore	O
,	O
they	O
suggest	O
that	O
CD169	O
(+	I:C0142251
)	I:C0142251
phagocytes	O
play	O
a	O
key	O
role	O
in	O
the	O
pathophysiology	O
of	O
multiple	B:C0026769
sclerosis	I:C0026769
.	O

Hence	O
,	O
targeting	O
CD169	B:C0142251
(+	I:C0142251
)	I:C0142251
phagocytes	O
may	O
hold	O
therapeutic	O
value	O
for	O
multiple	O
sclerosis	I:C0026769
.	O

Hence	O
,	O
targeting	O
CD169	O
(+	I:C0142251
)	I:C0142251
phagocytes	B:C0031307
may	O
hold	O
therapeutic	O
value	O
for	O
multiple	O
sclerosis	I:C0026769
.	O

Hence	O
,	O
targeting	O
CD169	O
(+	I:C0142251
)	I:C0142251
phagocytes	O
may	O
hold	O
therapeutic	O
value	O
for	O
multiple	B:C0026769
sclerosis	I:C0026769
.	O

